-
The disaster-affected market has skyrocketed. Will the market outlook for Shayuanzi continue to rise?
Time of Update: 2021-12-05
Astragalus complanatus is a small variety with concentrated production areas, and the price has not been high in recent years .
1. Astragalus complanatus is about to produce new products Bozhou market: In October this year, the production area of Astragalus complanatus was hit and prices rose rapidly.
-
National Anti-Monopoly Bureau listed!
Time of Update: 2021-12-05
On November 18, the State Antimonopoly Bureau was officially listed in the office building of the State Administration for Market Supervision and Administration . On the same day, the Anti-Monopoly
-
The sixth batch of national centralized procurement of insulin special procurement quotation forecast
Time of Update: 2021-12-05
Of course, there are also some factors that promote competition: First, "in principle, use the method of selection by difference", that is, groups with a large number of competing products are likely to implement the final elimination system, and companies that want to win the bid You must show enough sincerity to lower the price significantly to win the bid .
-
Tens of billions of antithrombotic drugs have fallen into the "Altar"! TOP10 ranking changes
Time of Update: 2021-12-05
According to data from Meinenet, the market for terminal antithrombotic drugs in public medical institutions in China in 2021H1 increased by 13.
Ticagrelor tablets ranked sixth in the TOP10 terminal antithrombotic drug products of China's public medical institutions in 2020, and fell out of the top ten in 2021H1 .
-
Ten billion cold Chinese patent medicine market TOP20 2 billion major varieties lead
Time of Update: 2021-12-05
As the best-selling category in the retail market, the terminal sales of cold Chinese patent medicines in physical pharmacies in Chinese cities have exceeded 10 billion yuan, and China Resources Sanjiu Pharmaceutical has continued to rank as the top seller .
-
Announcement of the China Food and Drug Administration on Revising the Instructions for Clodronate Disodium Preparations
Time of Update: 2021-12-04
The marketing authorization holders of the above-mentioned drugs shall comply with the relevant provisions of the "Administrative Measures for Drug Registration" and in accordance with the requirements for the revision of the instructions for clodronate disodium preparations (see attachment), on February 21, 2022 A few days ago, it was reported to the Drug Evaluation Center of the State Drug Administration or the provincial drug supervision and administration department for the record .
-
Some hospitals or transition nursing homes in 15 provinces to carry out pilot medical care for the elderly
Time of Update: 2021-12-04
In addition, pilot areas should encourage qualified primary medical institutions to set up and increase beds to provide elderly medical care services as needed .
-
Simcere's 14 new class 1 drugs and 5 blockbuster varieties are the first to be imitated!
Time of Update: 2021-12-04
The source of some innovative drugs under research by Simcere Pharmaceuticals: Meinenet China Drug Clinical Trial Public Library In the field of anti-tumor, Envolimab, which is cooperating with Siide Di and Corning Jerry, has submitted an NDA and has recently entered the administrative approval stage.
-
Domestic drugs accelerate their entry into the Parkinson’s disease market and the proportion of imported drugs in the Parkinson’s disease market drops by 4% in half a year
Time of Update: 2021-12-04
According to data from Meinenet, there are 15 chemically-named varieties of anti-Parkinson's disease drugs approved for marketing in China .
In 2020, the amount of anti-Parkinson's disease drugs used in public hospitals in key provinces and cities in China reached 620 million yuan, an increase of 8.
-
The selection criteria for Jiangxi "dual channel" pharmacies are here!
Time of Update: 2021-12-04
In accordance with the requirements of the National Medical Insurance Administration, local medical insurance departments must adhere to the principle of “openness, fairness, and justice”, determine selection criteria and procedures, and ensure compliance with qualifications, management practices, good reputation, and reasonable layout, and meet the Designated retail pharmacies with traceability and other conditions are included in the "dual channel" management, and they are proactively disclosed to the public in a timely manner .
-
Human blessing is attacking innovative drugs!
Time of Update: 2021-12-04
Recently, Renfu Medicine, the leading pharmaceutical company in anesthesia and sedation, once again sold huge assets to arouse industry attention.
In the field of neurological drugs, the company has also been approved for bupropion hydrochloride sustained-release tablets and levobupivacaine hydrochloride injection, and Renfu Medicine has won the first review .
-
The 14-province alliance's centralized procurement and regeneration change: 8 billion large varieties have been eliminated!
Time of Update: 2021-12-04
In fact, since the second half of 2020, more and more provinces (cities, districts) have successively formed inter-provincial alliances for centralized procurement .
-
28,000 plummeted to 6,000!
Time of Update: 2021-12-04
With the announcement of the results of this round of centralized procurement, so far, all high-value consumables for coronary interventional surgery have been reduced in price .
-
Even the price of Momordica grosvenori, which has been stable for many years, has begun to increase!
Time of Update: 2021-12-04
Momordica grosvenori is a variety that has maintained a stable price for many years. It has been new for two months this year, but the price has suddenly risen by 60% recently. What is the reason?
-
Online drug rebates?
Time of Update: 2021-12-04
The draft opinion stipulates that medical institutions should strictly abide by the "Prescription Management Measures" and other regulations when carrying out Internet diagnosis and treatment activities, strengthen drug management, and prohibit problems such as unified prescriptions and supplements .
-
Across 19 provinces, 76 large varieties are facing big exams... Is the national centralized procurement of Chinese patent medicine still far away?
Time of Update: 2021-12-04
At the same time, Niu Ben also believes that the "double envelope" adopted by the Hubei Alliance for the centralized procurement of Chinese patent medicines, based on the comprehensive scores and the rules of enterprise competition, also makes price reduction not the only criterion for winning bids.
-
The topical analgesic plaster with a market of over 18 billion "rules the king"!
Time of Update: 2021-12-03
Among the TOP5 products of China's public medical institutions, Tide's flurbiprofen gel plaster (Zepusi® Debam®) ranked first, with the highest growth rate and the only chemical drug on the list .
-
Forecast of the seventh batch of centralized procurement of anti-tumor drugs! Over 4 billion market
Time of Update: 2021-12-03
com shows that in 2020, the terminal sales of anti-tumor drugs in China's urban public hospitals, county-level public hospitals, urban community centers and township health centers (Chinese public medical institutions) will exceed 100 billion yuan, a year-on-year increase 10.
-
Over 6 billion large varieties!
Time of Update: 2021-12-03
According to data from Mi Nei. com, the total sales of this product in China's public medical institutions and physical pharmacies in Chinese cities will exceed 6 billion yuan in 2020.
-
The future of the 100 billion yuan dental implant market can be expected
Time of Update: 2021-12-03
It is foreseeable that whether it is included in centralized procurement or medical insurance, the accessibility of dental implants in China will be improved, the market demand will be greatly released, and the industry will usher in new development opportunities .
